We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
BEEN London is a next-generation sustainable accessory brand which converts waste into beautiful products, for customers all around the world. They aim to change the way people make, perceive and buy beautiful things and want to make everyone part of the solution, involving local artisans and people with learning disabilities in the growing economy of sustainable fashion. Till now, they have successfully shipped orders to 18 countries worldwide, achieved profitability from Year 1 and launched 17 different products including backpacks, laptop cases and tote bags. BEEN is a UK FUTURE 20 startup, a finalist at the Sustainable Lifestyle Awards, and a profitable company looking to scale up into a global, game-changing sustainable brand.  BEEN have been approved for investment by London Fashion Fund. With the funds, they want to accelerate sales, increase margins and turn other streams of waste into new incredible products.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £325,589
Fighter Shots (FS) is a company that makes daily energy shots from a range of sources like ginger, turmeric and manuka honey to boost and strengthen human immunity. FS has sold over 50,000 bottles since its launch in November 2019. The functional drinks market has the potential to grow by $180 billion (11% CAGR) to $270 billion from 2020-24 on the back of COVID-19. FS aims to be a disruptor in this segment and asserts that its a dependable substitute to coffee and sugary drinks. It has secured listings with the Health Store, Tree of Life and DDC. The company is also developing sales in the United Arab Emirates (UAE). FS will use the investment to build its digital marketing and sales capabilities to bring its product to more customers.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £160,000
Brew Monster is a Cwmbran-based microbrewery and also the winner of Beverage Industry Award in the Cardiff Regional Awards 2018. It serves primarily the South Wales region, including Cardiff, Newport and Swansea, and is increasingly gaining nation-wide popularity. In just 16 months since its establishment in 2017, Brew Monster has garnered a quarterly turnover of approximately £70,000 (Oct-Dec 2018). In this short period of time, the brewery has also doubled their production capacity, established a profitable micropub and set up a brewery tap.
days to go: Expired investment: £99,250
Revolupin Lupin flakes are the tasty, plant-based, certified vegan, pre-biotic, gluten-free, high-fibre and low-carb superfood. It is ready to make full use of the huge increase of 27% growth (2013-2015) in sports nutrition sales and the new market opportunity for being a 100% natural plant-based protein. Revolupin had won the Women’s Health Best Superfood Award in 2018. It has also secured a successful distribution via Wholefoods Wholesale and The Health Store. Revolupin has also launched a new online store on its official website. With its proceeds, the company will increase its production, sales and generate brand awareness. Revolupin will support retail, build the distribution network, and develop new recipes of ready-to-use food items and products.
days to go: Expired investment: £77,110
The Active Kollection (TAK) is an online store that sources running and cycling brands from around the world. The company is aiming to build a community of enthusiasts by making gear that will give them the performance, aesthetic and durability they desire. The sports and outdoor fashion market is expected to rise to £10.6 billion in 2022. TAK endeavours to become a major contender in this category. TAK's platform is live with 16 independent brands. The company has 54,000 followers across Twitter, Facebook and Instagram. It requires investment to accelerate its growth and continue its search to become the world’s most stylish running and cycling gear brand.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £69,432
Hemspan states that it designs bio-based building systems and products for construction by combining modern methods, technology and hemp to produce net-zero carbon solutions. The company argues that every time an average house is built, the CO2 emitted by the manufacture, transport and assembly of the materials used is around 50 to 60 tonnes. Hemspan says that one hectare of UK-grown industrial hemp can absorb 11 tonnes of CO2 each year with regeneratively farmed hemp capable of sequestering a further 6 tonnes per hectare of CO2 into the soil each year. Hemspan intends to activate significant demand for hemp farming in the UK and develop processing technologies to reduce reliance on imports and enable large scale manufacturing of bio-based cladding and insulation products that spin out of R&D programmes. It asserts that the global industrial hemp market is expected to grow at 25% CAGR reaching US$ 27 billion by 2028. It aims to be a contender in this segment. 
days to go: Expired investment: £200,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph